EPCLUSA Drug Profile, 2023: EPCLUSA (sofosbuvir; velpatasvir) drug patents, FDA exclusivity, litigation, drug prices

· DrugPatentWatch.com
Ebook
170
Pages
Eligible

About this ebook



<h2>EPCLUSA Drug Profile, 2023</h2>

<p>This report focuses on EPCLUSA and covers the following critical aspects of this drug:</p>

<ul><li>United States patents</li>

<li>District Court patent litigation</li>

<li>Patent Trial and Appeal Board (PTAB) patent cases</li>

<li>European supplementary protection certificates (SPCs)</li>

<li>Clinical trials</li>

<li>Drug prices</li>

<li>Finished product suppliers</li>

</ul>

Rate this ebook

Tell us what you think.

Reading information

Smartphones and tablets
Install the Google Play Books app for Android and iPad/iPhone. It syncs automatically with your account and allows you to read online or offline wherever you are.
Laptops and computers
You can listen to audiobooks purchased on Google Play using your computer's web browser.
eReaders and other devices
To read on e-ink devices like Kobo eReaders, you'll need to download a file and transfer it to your device. Follow the detailed Help Center instructions to transfer the files to supported eReaders.